This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alman, B. A. Articles by Wolfe, H. J. Search for Related Content PubMed PubMed Citation Articles by Alman, B. A. Articles by Wolfe, H. J.

American Journal of Pathology, Vol 151, 329-334, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)

BA Alman, C Li, ME Pajerski, S Diaz-Cano and HJ Wolfe
Department of Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.

Sporadic aggressive fibromatosis (also called desmoid tumor) is a monoclonal proliferation of spindle (fibrocyte-like) cells that is locally invasive but does not metastasize. A similarity to abdominal fibromatoses (desmoids) in familial adenomatous polyposis and a cytogenetic study showing partial deletion of 5q in a subset of aggressive fibromatoses suggests that the adenomatous polyposis coli (APC) gene plays a role in its pathogenesis. APC helps regulate the cellular level of beta-catenin, which is a downstream mediator in Wnt (Wingless) signaling. beta-Catenin has a nuclear function (binds transcription factors) and a cell membrane function (is a component of epithelial cell adherens junctions). Six cases of aggressive fibromatosis of the extremities from patients without familial adenomatous polyposis, or a family history of colon cancer, were studied. Immunohistochemistry, using carboxy and amino terminus antibodies to APC, and DNA sequencing showed that three of the six contained an APC-truncating mutation, whereas normal tissues did not contain a mutation. Western blot and Northern dot blot showed that all six tumors had a higher level of beta-catenin protein than surrounding normal tissues, despite containing similar levels of beta-catenin mRNA. Immunohistochemistry localized beta-catenin throughout the cell in tumor tissues, although it localized more to the periphery in cells from normal tissues. Reverse transcription polymerase chain reaction showed that the tumors expressed N-cadherin but not E-cadherin (a pattern of expression of proteins making up adherens junctions similar to fibrocytes), suggesting that the specific adherens junctions present in epithelial cells are not necessary for beta-catenin function. Increased beta-catenin may cause the growth advantage of cells in this tumor through a nuclear mechanism. The increased protein level, relative to the RNA level, suggests that beta-catenin is degraded at a lower rate compared with normal tissues. In some cases, this is caused by a somatic mutation resulting in a truncated APC protein.

This article has been cited by other articles:

				H. S. Hosalkar, J. T. Torbert, E. J. Fox, T. F. Delaney, A. J. Aboulafia, and R. D. Lackman Musculoskeletal Desmoid Tumors J. Am. Acad. Ortho. Surg., April 1, 2008; 16(4): 188 - 198. [Abstract] [Full Text] [PDF]

				D. Lev, D. Kotilingam, C. Wei, M. T. Ballo, G. K. Zagars, P. W.T. Pisters, A. A. Lazar, S. R. Patel, R. S. Benjamin, and R. E. Pollock Optimizing Treatment of Desmoid Tumors J. Clin. Oncol., May 1, 2007; 25(13): 1785 - 1791. [Abstract] [Full Text] [PDF]

				M. C. Heinrich, G. A. McArthur, G. D. Demetri, H. Joensuu, P. Bono, R. Herrmann, H. Hirte, S. Cresta, D. B. Koslin, C. L. Corless, et al. Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor) J. Clin. Oncol., March 1, 2006; 24(7): 1195 - 1203. [Abstract] [Full Text] [PDF]

				Y. Kong, R. Poon, P. Nadesan, T. Di Muccio, R. Fodde, R. Khokha, and B. A. Alman Matrix Metalloproteinase Activity Modulates Tumor Size, Cell Motility, and Cell Invasiveness in Murine Aggressive Fibromatosis Cancer Res., August 15, 2004; 64(16): 5795 - 5803. [Abstract] [Full Text] [PDF]

				M. Chilosi, V. Poletti, A. Zamo, M. Lestani, L. Montagna, P. Piccoli, S. Pedron, M. Bertaso, A. Scarpa, B. Murer, et al. Aberrant Wnt/{beta}-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis Am. J. Pathol., May 1, 2003; 162(5): 1495 - 1502. [Abstract] [Full Text] [PDF]

				S. S. Cheon, A. Y. L. Cheah, S. Turley, P. Nadesan, R. Poon, H. Clevers, and B. A. Alman beta -Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds PNAS, May 14, 2002; 99(10): 6973 - 6978. [Abstract] [Full Text] [PDF]

				T Naka, Y Oda, Y Iwamoto, N Shinohara, H Chuman, M Fukui, and M Tsuneyoshi Immunohistochemical analysis of E-cadherin, {alpha}-catenin, {beta}-catenin, {gamma}-catenin, and neural cell adhesion molecule (NCAM) in chordoma J. Clin. Pathol., December 1, 2001; 54(12): 945 - 950. [Abstract] [Full Text] [PDF]

				X. Meng, R. Poon, X. Zhang, A. Cheah, Q. Ding, C.-c. Hui, and B. Alman Suppressor of Fused Negatively Regulates beta -Catenin Signaling J. Biol. Chem., October 19, 2001; 276(43): 40113 - 40119. [Abstract] [Full Text] [PDF]

				J. R. Woodgett Judging a Protein by More Than Its Name: GSK-3 Sci. Signal., September 18, 2001; 2001(100): re12 - re12. [Abstract] [Full Text] [PDF]

				S. C. Abraham, E. A. Montgomery, F. M. Giardiello, and T.-T. Wu Frequent {beta}-Catenin Mutations in Juvenile Nasopharyngeal Angiofibromas Am. J. Pathol., March 1, 2001; 158(3): 1073 - 1078. [Abstract] [Full Text] [PDF]

				P. Polakis Wnt signaling and cancer Genes & Dev., August 1, 2000; 14(15): 1837 - 1851. [Full Text]

				C. Li, B. Bapat, and B. A. Alman Adenomatous Polyposis Coli Gene Mutation Alters Proliferation through its ß-Catenin-Regulatory Function in Aggressive Fibromatosis (Desmoid Tumor) Am. J. Pathol., September 1, 1998; 153(3): 709 - 714. [Abstract] [Full Text] [PDF]